GlassScriptPhysician profile
Christopher Michael Bates
NPI 1730524596
$16,903.30
in general payments reported to CMS, 2019-2025
19 companies · $7,165 in 2025
The $7,165 reported for 2025 was more than what 94% of Plastic and Reconstructive Surgery providers received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $746 · 2020: $273 · 2021: $651 · 2022: $2,471 · 2023: $1,374 · 2024: $4,223 · 2025: $7,165.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,543 · Travel and Lodging: $3,633 · Consulting Fee: $2,500 · Gift: $87.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,542.61 |
| Travel and Lodging | $3,632.68 |
| Consulting Fee | $2,500.00 |
| Gift | $87.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $7,955.54 | 2023-2025 | Natrelle Saline-Filled Breast Implants, Botox |
| Motiva USA, LLC | $3,343.54 | 2024-2025 | |
| Allergan, INC. | $1,464.44 | 2019-2022 | |
| Medical Device Business Services, INC. | $1,119.32 | 2022 | |
| Sientra, INC. | $734.34 | 2020-2022 | |
| Tela Bio, INC. | $546.17 | 2024-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Mentor Worldwide LLC | $395.84 | 2020-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Davol INC. | $372.69 | 2022-2023 | Arista Ah Flexitip, Phasix Mesh |
| Zimmer Biomet Holdings, INC. | $264.69 | 2019 | |
| Integra Lifesciences Corporation | $201.66 | 2019-2023 | Durasorb Monofilament Mesh |
| W. L. Gore & Associates, INC. | $151.60 | 2025 | Gore Enform Preperitoneal Biomaterial |
| Axogen | $112.36 | 2019 | |
| Merz North America, INC. | $57.78 | 2024 | |
| Vertex Pharmaceuticals Incorporated | $55.85 | 2025 | Journavx |
| Smith+Nephew, INC. | $37.04 | 2023 | Lens 4k |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $26.79 | 2022-2023 | Bair Paws, Tegaderm, Prevena |
| Solta Medical, A Division of Bausch Health US, LLC | $23.86 | 2019 | |
| Ethicon US, LLC | $21.48 | 2025 | Stratafix |
| Pacira Pharmaceuticals Incorporated | $18.31 | 2023 | Exparel, Iovera |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bates listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.